David M. Goldstein's most recent trade in Alumis Inc. was a trade of 107,950 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 107,950 | 107,950 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 27,000 | 29,115 | - | 0 | Common Stock | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 213,903 | 213,903 | - | - | Common Stock | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 213,903 | 0 | - | - | Class A Common Stock | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 206,074 | 206,074 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 206,074 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 171,122 | 171,122 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 171,122 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 53,475 | 53,475 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 53,475 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 42,780 | 42,780 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 42,780 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 30,642 | 30,642 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 30,642 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 11,978 | 11,978 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 11,978 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 2,994 | 2,994 | - | - | Common Stock | |
| Alumis Inc. | David M. Goldstein | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2024 | 2,994 | 0 | - | - | Class A Common Stock |